Comparative Population Pharmacokinetics of Darunavir in SARS-CoV-2 Patients vs. HIV Patients: The Role of Interleukin-6

ConclusionsThis is a proof-of-concept of SARS-CoV-2 disease –drug interactions, and may support the need for optimal dose selection of sensitive CYP3A4 substrates in severe SARS-CoV-2 patients.
Source: Clinical Pharmacokinetics - Category: Drugs & Pharmacology Source Type: research